Central European Journal of Medicine

, Volume 4, Issue 3, pp 310–314 | Cite as

The effects of oxcarbazepine treatment on vitamin B12 and folate levels, thyroid functions, sex hormones, and bone mineral density in epileptic patients

  • Sebahattin Vurucu
  • Mustafa Gulgun
  • Ediz Yesilkaya
  • Bulent Unay
  • Ridvan Akin
Research Article
  • 64 Downloads

Abstract

The aim of this study was to evaluate vitamin B12 and folate levels, thyroid functions, sex hormones and bone mineral density in idiopathic epileptic patients taking oxcarbazepine as monotherapy. Newly diagnosed pediatric patients with idiopathic partial epilepsy taking oxcarbazepine (OXC) as monotherapy were enrolled in this study. The pre-treatment and 6 months post-treatment values of vitamin B12, folate, thyroid functions, sex hormones, and bone mineral density (BMD) were obtained from all patients. A total of 32 patients (22 (68.8%) males and 10 (31.2%) females) were included in this study. The mean age was 7.4 ± 3.2 years (range: 2–14 years). There were no significant differences between the pre-treatment and 6 months post-treatment values of vitamin B12, folate, thyroid functions, sex hormones, and BMD. However, the 6 month post-treatment sex hormone binding globulin (SHBG) values (159.92 ± 48.14 nmol/L) were significantly higher than the pre-treatment values (137.88 ± 43.12 nmol/L) (p=0.009). We found that OCX treatment in children did not have an effect on serum folate and vitamin B12 levels, thyroid functions, sex hormones and BMD but caused increased SHBG. Over time, the increase in serum SHBG levels may lead to diminished bioactivity of sex steroids, and thus to reduced fertility. The further studies are needed to demonstrate the clinical importance of increased SHBG levels.

Keywords

Epilepsy Oxcarbazepine Vitamin B12 Hormones Bone mineral density 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Karabiber H., Sonmezgoz E., Ozerol E., Yakinci C., Otlu B., Yologlu S., Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Develop., 2003, 25, 113–115CrossRefGoogle Scholar
  2. [2]
    Ueland P.M., Refsum H., Beresford S.A.A., Vollset S.E., The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr., 2000, 72, 324–332PubMedGoogle Scholar
  3. [3]
    Yoo J.H., Hong S.B., A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism, 1999, 48, 1047–1051PubMedCrossRefGoogle Scholar
  4. [4]
    Apeland T., Mansoor M.A., Pentieva K., McNulty H., Seljeflot I., Strandjord R.E., The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy Res., 2002, 51, 237–247PubMedCrossRefGoogle Scholar
  5. [5]
    Apeland T., Mansoor M.A., Strandjord R.E., Vefring H., Kristensen O., Folate, homocysteine and methionine loading in patients on carbamazepine. Acta Neurol. Scand., 2001, 103, 294–299PubMedCrossRefGoogle Scholar
  6. [6]
    Hendel J., Dam M., Gram L., The effects of carbamazepine and valproate on folate metabolism in man. Acta Neurol. Scand., 1984, 69, 226–231PubMedCrossRefGoogle Scholar
  7. [7]
    Verotti A., Basciani F., Morresi S., Morgese G., Chiarelli F., Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatric Neurol., 2001, 25, 43–46CrossRefGoogle Scholar
  8. [8]
    Leena K.V., Kirsi M., Johanna R., Mikael K., Arto J.P., Vilho V.M., et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproat monotherapy and after withdrawal of medication. Epilpesia, 2004, 45, 197–203CrossRefGoogle Scholar
  9. [9]
    Isojarvi J.I.T., Pakarinen A.J., Ylipalosaari P.J., Myllyla V.V., Serum hormones in male epileptic patients receiving anticonvulsant medication. Pediatric Neurol., 1990, 47, 670–676Google Scholar
  10. [10]
    Kirsi M., Paivi T., Arto J.P., Markku P., Jouko I.T.I., Leena K.V., Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy. Epilepsia, 2004, 45, 769–776CrossRefGoogle Scholar
  11. [11]
    Johanna R., Leena V., Mikeal K., Peter L., Jouko I.T.İ., The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics, 1999, 103, 588–593CrossRefGoogle Scholar
  12. [12]
    Alison M.P., Lucia S.O., Martha J.M., Edith F., Stanley R.R., Elisabeth S., Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav., 2003, 4, 169–174CrossRefGoogle Scholar
  13. [13]
    Imran I.A., Gregory L.B., John R.G., Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav., 2004, 5, 296–300CrossRefGoogle Scholar
  14. [14]
    Kulak C.A.M., Borba V.Z.C., Bilezikian J.P., Silvado C.E., Paola de L., Boguszewski C.L., Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arg. Neuropsiquiatr., 2000, 62, 940–948Google Scholar
  15. [15]
    Filardi S., Guerreiro C.A.M., Neto J.F.M., Bone mineral density, vitamin D and anticonvulsant therapy. Arg. Neuropsiquatr., 2000, 58, 616–620Google Scholar
  16. [16]
    Akin R., Okutan V., Sarici S.U., Altunbas A., Gokçay E., Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr. Neurol., 1998, 19, 129–131PubMedCrossRefGoogle Scholar
  17. [17]
    Tamura T., Aiso K., Johnston K.E., Black L., Faught E., Homocysteine, folate, vitamin B12 and vitamin B6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res., 2000, 40, 7–15PubMedCrossRefGoogle Scholar
  18. [18]
    Porcharuniti N., Lewis CA., Plasma homocysteine, folate and vitamine B-12 concentrations and risk for early onset coronary disease. Am. J. Clin. Nutr., 1994, 59, 940–948Google Scholar
  19. [19]
    Dastur D., Dave U., Effect of prolonged anticonvulsant medication in epileptic patients: Serum lipids, vitamin B6, B12 and folic acid, proteins and fine structure of liver. Epilepsia, 1987, 28, 147–159PubMedCrossRefGoogle Scholar
  20. [20]
    Krause K.H., Bonjour J.P., Berlit P., Kynast G., Schmidt-Gayk H., Schellenberg B., Effect of long-term treatment with antiepileptic drugs on the vitamin status. Drug. Nutr. Interact., 1988, 5, 317–343PubMedGoogle Scholar
  21. [21]
    Reynold’s E., Chanarin I., Milner G., Matthews D., Anticonvulsant therapy folic acid and vitamin B12 metabolism and mental symptoms. Epilepsia, 1966, 7, 261–270CrossRefGoogle Scholar
  22. [22]
    Cansu A., Serdaroglu A., Camurdan O., Hirfanoglu T., Bideci A., Gucuyener K., The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Epilepsia, 2006, 47, 1855–1859PubMedCrossRefGoogle Scholar
  23. [23]
    Cramer J.A., Jones E.E., Reproductive function in epilepsy. Epilepsia, 1991, 32, 19–26CrossRefGoogle Scholar
  24. [24]
    Eiris-Punal J., Del-Rio Garma M., Del-Rio Garma M.C., Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia, 1999, 40, 1761–1766PubMedCrossRefGoogle Scholar
  25. [25]
    Caksen H., Dulger H., Cesur Y., Atas B., Tuncer O., Odabas D., Evaluation of thyroid and parathyroid functions in children receiving long-term carbamazepine therapy. Int. J. Neurosci., 2003, 113, 1213–1217PubMedCrossRefGoogle Scholar
  26. [26]
    Vainionpaa L.K., Rattya J., Knip M., Valproateinduced hyperandrogenism during pubertal maturation in girls with epilepsy. Pediatric Neurol., 1999, 45, 444–450Google Scholar
  27. [27]
    Ramsay R.E., Slater J.D., Effects of antiepileptic drugs on hormones. Epilepsia, 1991, 32, 60–67CrossRefGoogle Scholar
  28. [28]
    Isojarvi J.I., Taubll E., Herzog A.G., Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs, 2005, 19, 207–223PubMedCrossRefGoogle Scholar
  29. [29]
    Fenwick P.B.C., Toone B.K., Wheeler M.J., Nanje M.N., Grant R., Brown D., Sexual behaviour in a centre for epilepsy. Acta Neurol. Scand., 1985, 71, 428–435PubMedCrossRefGoogle Scholar
  30. [30]
    Vestergaard P., Epilepsy, osteoporosis and fracture risk — a meta-analysis. Acta Neurol. Scand., 2005, 112, 277–286PubMedCrossRefGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Sebahattin Vurucu
    • 1
  • Mustafa Gulgun
    • 1
  • Ediz Yesilkaya
    • 1
  • Bulent Unay
    • 1
  • Ridvan Akin
    • 1
  1. 1.Gulhane Military Medical Academy Department of Pediatric NeurologyEtlik, AnkaraTurkey

Personalised recommendations